| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 138, Issue 11 3817-3823, Copyright © 1987 by American Association of Immunologists
ARTICLES |
WW Cruikshank, JS Berman, AC Theodore, J Bernardo and DM Center
The function of the T4 antigen, a marker for a differentiated T cell subset, is not well understood. Our previous observation that a chemoattractant human lymphokine, lymphocyte chemoattractant factor (LCF), which selectively induces motile responses in unactivated T4+ lymphocytes, led us to investigate whether LCF could also induce T4+ cell activation. Because LCF acts selectively on T4+ cells, we next determined whether the T4 antigen has a function in this LCF-induced cellular activation. A T4+ lymphocyte migratory response is induced by divalent anti-T4 antibody, but not by corresponding Fab fragments of the same antibody. Fab fragments of anti-T4 antibody, but not Fab fragments of anti-T3 antibody, block the migratory effect of both LCF and divalent anti-T4. Furthermore, LCF but not divalent anti-T4, evokes the expression of interleukin 2 (IL 2) receptors and HLA-DR antigen on T4+ lymphocytes in 24 hr. These effects are quantitatively similar to those observed by anti-T3 antibody activation. LCF-induced IL 2 receptor expression is blocked by co-incubation with anti-T4 antibody and anti-T4 Fab fragments, whereas anti-T3 activation is not inhibitable by anti-T4 Fab fragments. Because cultured monocytes express the T4 antigen, we investigated the action of LCF on cultured monocyte migration and HLA-DR expression. Induction of monocyte migration by LCF and anti-T4 antibody increases proportionally as T4 antigen expression increases in vitro. This enhanced migration is inhibitable by anti-T4 Fab fragments. Monocyte activation, as measured by augmented HLA-DR expression 24 hr after incubation with LCF, but not anti-T4 antibody, is quantitatively similar to the effects of interferon-gamma. Augmented HLA-DR expression is blocked by anti-T4 Fab fragments but not by antibody to interferon-gamma. These studies indicate that LCF interacts with T4+ lymphocytes and monocytes to induce migration and cellular activation.
This article has been cited by other articles:
|
|
 |
|
  C. McFadden, R. Morgan, S. Rahangdale, D. Green, H. Yamasaki, D. Center, and W. Cruikshank Preferential Migration of T Regulatory Cells Induced by IL-16 J. Immunol., November 15, 2007; 179(10): 6439 - 6445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Gianoukakis, R. S. Douglas, C. S. King, W. W. Cruikshank, and T. J. Smith Immunoglobulin G from Patients with Graves' Disease Induces Interleukin-16 and RANTES Expression in Cultured Human Thyrocytes: A Putative Mechanism for T-Cell Infiltration of the Thyroid in Autoimmune Disease Endocrinology, April 1, 2006; 147(4): 1941 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rahangdale, R. Morgan, C. Heijens, T. C. Ryan, H. Yamasaki, E. Bentley, E. Sullivan, D. M. Center, and W. W. Cruikshank Chemokine Receptor CXCR3 Desensitization by IL-16/CD4 Signaling Is Dependent on CCR5 and Intact Membrane Cholesterol J. Immunol., February 15, 2006; 176(4): 2337 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Desnues, M. Ihrig, D. Raoult, and J.-L. Mege Whipple's Disease: a Macrophage Disease Clin. Vaccine Immunol., February 1, 2006; 13(2): 170 - 178. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Qi, J. Wang, S. Mandadi, K. Tanaka, B. D. Roufogalis, M. C. Madigan, K. Lai, F. Yan, B. H. Chong, R. L. Stevens, et al. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor Blood, January 1, 2006; 107(1): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Lynch, C. A. W. Heijens, N. F. Horst, D. M. Center, and W. W. Cruikshank Cutting Edge: IL-16/CD4 Preferentially Induces Th1 Cell Migration: Requirement of CCR5 J. Immunol., November 15, 2003; 171(10): 4965 - 4968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Archin, L. van den Boom, L. Perelygina, J. M. Hilliard, and S. S. Atherton Delayed Spread and Reduction in Virus Titer after Anterior Chamber Inoculation of a Recombinant of HSV-1 Expressing IL-16 Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3066 - 3076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Gianoukakis, L. J. Martino, N. Horst, W. W. Cruikshank, and T. J. Smith Cytokine-Induced Lymphocyte Chemoattraction from Cultured Human Thyrocytes: Evidence for Interleukin-16 and Regulated upon Activation, Normal T Cell Expressed, and Secreted Expression Endocrinology, July 1, 2003; 144(7): 2856 - 2864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pritchard, R. Han, N. Horst, W. W. Cruikshank, and T. J. Smith Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves' Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway J. Immunol., June 15, 2003; 170(12): 6348 - 6354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. F. Little, E. Lynch, G. Fine, D. M. Center, and W. W. Cruikshank Tumor Necrosis Factor-{alpha}-Induced Synthesis of Interleukin-16 in Airway Epithelial Cells: Priming for Serotonin Stimulation Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 354 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Cristillo and B. E. Bierer Identification of Novel Targets of Immunosuppressive Agents by cDNA-based Microarray Analysis J. Biol. Chem., February 1, 2002; 277(6): 4465 - 4476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pritchard, N. Horst, W. Cruikshank, and T. J. Smith Igs from Patients with Graves' Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts J. Immunol., January 15, 2002; 168(2): 942 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Little, W. W. Cruikshank, and D. M. Center IL-9 Stimulates Release of Chemotactic Factors from Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 347 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaser, S. Dunzendorfer, F. A. Offner, O. Ludwiczek, B. Enrich, R. O. Koch, W. W. Cruikshank, C. J. Wiedermann, and H. Tilg B Lymphocyte-Derived IL-16 Attracts Dendritic Cells and Th Cells J. Immunol., September 1, 2000; 165(5): 2474 - 2480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. KRUG, W. W. CRUIKSHANK, T. TSCHERNIG, V. J. ERPENBECK, K. BALKE, J. M. HOHLFELD, D. M. CENTER, and H. FABEL Interleukin 16 and T-cell Chemoattractant Activity in Bronchoalveolar Lavage 24 Hours after Allergen Challenge in Asthma Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 105 - 111. [Abstract] [Full Text]
|
|
|
|
|
|
D. Sciaky, W. Brazer, D. M. Center, W. W. Cruikshank, and T. J. Smith Cultured Human Fibroblasts Express Constitutive IL-16 mRNA: Cytokine Induction of Active IL-16 Protein Synthesis Through a Caspase-3-Dependent Mechanism J. Immunol., April 1, 2000; 164(7): 3806 - 3814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Graziani-Bowering and L. G. Filion Down Regulation of CD4 Expression following Isolation and Culture of Human Monocytes Clin. Vaccine Immunol., March 1, 2000; 7(2): 182 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Mashikian, T. C. Ryan, A. Seman, W. Brazer, D. M. Center, and W. W. Cruikshank Reciprocal Desensitization of CCR5 and CD4 Is Mediated by IL-16 and Macrophage-Inflammatory Protein-1{beta}, Respectively J. Immunol., September 15, 1999; 163(6): 3123 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaser, S. Dunzendorfer, F. A. Offner, T. Ryan, A. Schwabegger, W. W. Cruikshank, C. J. Wiedermann, and H. Tilg A Role for IL-16 in the Cross-Talk Between Dendritic Cells and T Cells J. Immunol., September 15, 1999; 163(6): 3232 - 3238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]
|
|
|
|
|
|
J. Nicoll, W. W. Cruikshank, W. Brazer, Y. Liu, D. M. Center, and H. Kornfeld Identification of Domains in IL-16 Critical for Biological Activity J. Immunol., August 15, 1999; 163(4): 1827 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, W. W. Cruikshank, T. O'Loughlin, P. O'Reilly, D. M. Center, and H. Kornfeld Identification of a CD4 Domain Required for Interleukin-16 Binding and Lymphocyte Activation J. Biol. Chem., August 13, 1999; 274(33): 23387 - 23395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhou, K. Devadas, D. Tewari, A. Jegorow, and A. L. Notkins Processing, Secretion, and Anti-HIV-1 Activity of IL-16 With or Without a Signal Peptide in CD4+ T Cells J. Immunol., July 15, 1999; 163(2): 906 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. PACE, M. GJOMARKAJ, M. MELIS, M. PROFITA, M. SPATAFORA, A. M. VIGNOLA, G. BONSIGNORE, and C. H. MODY Interleukin-8 Induces Lymphocyte Chemotaxis into the Pleural Space . Role of Pleural Macrophages Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1592 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cao, W. Zhang, L. He, Z. Xie, S. Ma, Q. Tao, Y. Yu, H. Hamada, and J. Wang Lymphotactin Gene-Modified Bone Marrow Dendritic Cells Act as More Potent Adjuvants for Peptide Delivery to Induce Specific Antitumor Immunity J. Immunol., December 1, 1998; 161(11): 6238 - 6244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Chupp, E. A. Wright, D. Wu, M. Vallen-Mashikian, W. W. Cruikshank, D. M. Center, H. Kornfeld, and J. S. Berman Tissue and T Cell Distribution of Precursor and Mature IL-16 J. Immunol., September 15, 1998; 161(6): 3114 - 3119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Keane, J. Nicoll, S. Kim, D. M. H. Wu, W. W. Cruikshank, W. Brazer, B. Natke, Y. Zhang, D. M. Center, and H. Kornfeld Conservation of Structure and Function Between Human and Murine IL-16 J. Immunol., June 15, 1998; 160(12): 5945 - 5954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Hessel, W. W. Cruikshank, I. Van Ark, J. J. De Bie, B. Van Esch, G. Hofman, F. P. Nijkamp, D. M. Center, and A. J. M. Van Oosterhout Involvement of IL-16 in the Induction of Airway Hyper-Responsiveness and Up-Regulation of IgE in a Murine Model of Allergic Asthma J. Immunol., March 15, 1998; 160(6): 2998 - 3005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Parada, D. M. Center, H. Kornfeld, W. L. Rodriguez, J. Cook, M. Vallen, and W. W. Cruikshank Synergistic Activation of CD4+ T Cells by IL-16 and IL-2 J. Immunol., March 1, 1998; 160(5): 2115 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Laberge, P. Ernst, O. Ghaffar, W. W. Cruikshank, H. Kornfeld, D. M. Center, and Q. Hamid Increased Expression of Interleukin-16 in Bronchial Mucosa of Subjects with Atopic Asthma Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 193 - 202. [Abstract] [Full Text]
|
|
|
|
|
|
T. C. Ryan, W. W. Cruikshank, H. Kornfeld, T. L. Collins, and D. M. Center The CD4-associated Tyrosine Kinase p56[IMAGE] Is Required for Lymphocyte Chemoattractant Factor-induced T Lymphocyte Migration J. Biol. Chem., July 21, 1995; 270(29): 17081 - 17086. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
